Advanced search
Publication Cover
Neuro-Ophthalmology Volume 39, 2015 - Issue 3
Submit an article Journal homepage
196
Views
16
CrossRef citations to date
0
Altmetric
Review

Rituximab in the Treatment of Thyroid Eye Disease: A Review

Rochella A. OstrowskiDivision of Allergy, Immunology, and Rheumatology, Department of Medicine, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA and Correspondence[email protected]
,
Melissa R. BusseyDivision of Allergy, Immunology, and Rheumatology, Department of Medicine, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA and
,
Yasmin ShayestehDepartment of Ophthalmology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA
&
Walter M. JayDepartment of Ophthalmology, Loyola University Chicago, Stritch School of Medicine, Maywood, Illinois, USA
Pages 109-115 | Received 06 Feb 2015, Accepted 06 Apr 2015, Published online: 17 Jun 2015

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Emmett T. Cunningham$suffix/text()$suffix/text(), Caleb Ng, Eric B Suhler & Derrick P. Smit. (2022) Rituximab for Ocular Inflammatory Disease. Ocular Immunology and Inflammation 30:6, pages 1300-1302.
Read now
Lauren Hennein & Shira L. Robbins. (2022) Thyroid-Associated Orbitopathy: Management and Treatment. Journal of Binocular Vision and Ocular Motility 72:1, pages 32-46.
Read now

Articles from other publishers (14)

Pratheeba Devi Nivean, Nivean Madhivanan, Govindasamy Kumaramanikavel, Tos T. J. M. Berendschot, Carroll A. B. Webers & Dion Paridaens. (2023) Understanding the clinical and molecular basis of thyroid orbitopathy: a review of recent evidence. Hormones.
Crossref
Kun Yang, Ya‐Ji Xu, Yan He, Cheng‐Xin Duan, Huai‐Fu Wang & Wei‐Jun Ding. (2022) Hyperoxia combined with the B‐cell antagonist rituximab led to intestinal dysbiosis in neonatal mice. Microbiology and Immunology 66:7, pages 353-360.
Crossref
Swan Kang, Shirin Hamed Azzam, Neda Minakaran & Daniel G Ezra. (2022) Rituximab for thyroid-associated ophthalmopathy. Cochrane Database of Systematic Reviews 2022:6.
Crossref
Vardaan Gupta, Christine L. Hammond, Elisa Roztocil, Mithra O. Gonzalez, Steven E. Feldon & Collynn F. Woeller. (2022) Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease. Survey of Ophthalmology 67:3, pages 858-874.
Crossref
Loreley D. SmithEve E. MoscatoStuart R. Seiff. (2021) Tocilizumab for the Management of Thyroid-Associated Orbitopathy. Ophthalmic Plastic & Reconstructive Surgery 38:2, pages 188-192.
Crossref
Pei-Wen Cheng, Pei-Jhen Tsai, Ming-Hong Tai & Youn-Shen Bee. (2021) Therapeutic Effect of α-MSH in Primary Cultured Orbital Fibroblasts Obtained from Patients with Thyroid Eye Disease. International Journal of Molecular Sciences 22:20, pages 11225.
Crossref
Amber Jimenez, Christopher Hull & John Zone. (2021) Rituximab therapy for a severe case of pretibial myxedema. JAAD Case Reports 10, pages 28-30.
Crossref
Rona Z. Silkiss, Michael K. Paap, Kelsey A. Roelofs, Jorge Agi & Ezekiel Weis. (2021) Treatment of corticosteroid-resistant thyroid eye disease with subcutaneous tocilizumab. Canadian Journal of Ophthalmology 56:1, pages 66-70.
Crossref
Guo Chen, Yungang Ding, Qian Li, Yanbing Li, Xiaofeng Wen, Xian Ji, Shaowei Bi, Jingqiao Chen, Jianan Xu, Rongxin Chen, Huijing Ye, Lai Wei & Huasheng Yang. (2019) Defective Regulatory B Cells Are Associated With Thyroid-Associated Ophthalmopathy. The Journal of Clinical Endocrinology & Metabolism 104:9, pages 4067-4077.
Crossref
Svenja PlöhnMatthias HoseAnke SchlüterLars MichelSalvador Diaz-CanoUlrike B. Hendgen-CottaJasvinder Paul BangaNikolaos E. BechrakisWiebke HansenAnja EcksteinUtta Berchner-Pfannschmidt. (2019) Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor. Thyroid 29:9, pages 1286-1301.
Crossref
Elizabeth A. Insull, Zuzana Sipkova, Joel David, Helen E. Turner & Jonathan H. Norris. (2019) Early low‐dose rituximab for active thyroid eye disease: An effective and well‐tolerated treatment. Clinical Endocrinology.
Crossref
Aldo Ferreira-Hermosillo, Ruben Casados-V, Pedro Paúl-Gaytán & Victoria Mendoza-Zubieta. (2018) Utility of rituximab treatment for exophthalmos, myxedema, and osteoarthropathy syndrome resistant to corticosteroids due to Graves’ disease: a case report. Journal of Medical Case Reports 12:1.
Crossref
Zhen Li, Dean M. Cestari & Elizabeth Fortin. (2018) Thyroid eye disease. Current Opinion in Ophthalmology 29:6, pages 528-534.
Crossref
Andrey Bychkov & Chan Kwon Jung. (2018) Aberrant expression of CD20 in thyroid cancer and its clinicopathologic significance. Human Pathology 71, pages 74-83.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.